全球腦保健補充劑市場：市場規模和佔有率分析 - 趨勢、驅動因素、競爭格局和預測（2024-2030）

市場概況

預計2023年全球腦保健補充品市場規模將達92.382億美元，2030年將達161.139億美元，2024年至2030年複合年增長率為8.4%。隨著人們認識到這是一種必需品，對用於增強注意力、記憶力和控制壓力（尤其是老年人）的各種保健補充劑的需求正在增加，從而推動了市場成長。

重要見解

預測期內，草藥萃取物類別（銀杏、薑黃素、人參、綠茶萃取物等）預計將以 8.7% 的複合年增長率成長。在中國和印度等新興國家，對草藥產品的需求正在增加。

天然分子品類將在2023年位居第二，佔全球收入的55%。與合成補充劑相比，對非合成補充劑的需求不斷增長。由於消費者的壓力，公司正在轉向將天然成分融入產品中。

2023 年，記憶體增強類別產生了最大的收入佔有率，約 30%。同時，成長第二快的類別是壓力和焦慮。

2023年，北美地區的產業佔有率為50%。這是由於人們對認知健康的興趣增加和體育部門的蓬勃發展。此外，在大腦健康問題、教育領域的壓力和需求的推動下，亞太地區預計將成長 9.0% 以上。

本報告分析了全球腦保健補充劑市場，包括市場的基本結構、最新情況、主要促進和抑制因素以及全球、依地區和主要國家的市場規模前景（基於價值，來自2017 年起），2030 年） ，依產品和應用劃分的詳細趨勢、市場競爭現狀以及主要公司概況。

目錄

第一章 調查範圍

第二章 研究方法

第三章執行摘要

第四章 市場指標

第五章 產業展望

• 市場動態
  • 趨勢
  • 促進因素
  • 抑制因素/課題
  • 促進/抑制因素影響分析
• 新型冠狀病毒感染（COVID-19）的影響
• 波特五力分析

第六章 世界市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依應用分類（2017-2030）
• 市場收入：依地區（2017-2030）

第七章 北美市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依應用分類（2017-2030）
• 市場收入：依國家分類（2017-2030）

第八章歐洲市場

第九章亞太市場

第十章 拉丁美洲市場

第十一章 中東/非洲市場

第十二章 美國市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依應用分類（2017-2030）

第十三章 加拿大市場

第十四章 德國市場

第十五章 法國市場

第十六章 英國市場

第十七章 義大利市場

第十八章 西班牙市場

第十九章 日本市場

第20章 中國市場

第21章 印度市場

第22章澳洲市場

第23章 韓國市場

第24章 巴西市場

第25章 墨西哥市場

第26章 沙烏地阿拉伯市場

第27章南非市場

第28章 阿拉伯聯合大公國（UAE）市場

第29章競爭格局

• 市場參與者及其產品清單
• 主要企業競爭基準
• 主要公司的產品基準
• 近期策略發展

第三十章 公司簡介

• AlternaScript LLC
• Natrol LLC
• Health Via Modern Nutrition Inc.
• KeyView Labs Inc.
• Natural Factors Nutritional Products Ltd.
• Onnit Labs Inc.
• Peak Nootropics LLC
• Purelife Bioscience Co. Ltd.
• Intelligent Labs
• Accelerated Intelligence Inc.
• NOW Foods

第31章附錄

Market Overview

The global brain health supplements market size was USD 9,238.2 million in 2023, and it is expected to reach USD 16,113.9 million by 2030, advancing with a CAGR of 8.4% during 2024-2030. As people realize this as a necessity, increasing demand for various health supplements used for attention and memory enhancement and to manage stress (especially in the elderly) is pushing the market growth.

However, beliefs matter in the layout of food and vitamin substances landscaping as it is growing more and more popular with the global community. People who are aware of the healthy way of tom revealing vegan habits are using those who can take plant-based omega-3 dietary supplements. According to Shanna Peevey, the director of consumer research, some sevenfold increase in people's interest in veganism has been registered during the last five to six years.

World Health Organization report points out that the number of people aged 60 and above will more than double between the 2015-2050 periods which was 12% at the beginning to 22% at the end. While older people can sometimes have depressive disorders, they tend to develop more memory loss, for example, Alzheimer's, migraine, Parkinson's, insomnia, and other conditions associated with the brain cells. Alzheimer's consists of diverse symptoms such as memory loss and speech impairment.

Key Insights

During the projection period, the herbal extracts category is projected to advance at 8.7% CAGR.

Comprises ingredients such as ginkgo biloba, curcumin, ginseng, and green tea extract.

Improves memory, brain blood flow, and cognitive function, and decreases mental fatigue.

Increasing need in emerging nations such as China and India for herbal items.

Ancient Chinese medication supplements are also marketed in Western markets.

Vitamins and minerals category to grow significantly, vital for brain function.

Offers B1, B2, B9, omega-3, necessary for neural function, headache reduction, brain wellness, and mood. Usually added into multivitamins.

The natural molecules category stood second in 2023 with 55% of the global revenue generated.

The rising demand for non-synthetic supplements compares with synthetic ones.

Companies are oriented towards natural ingredients embedded into products as a result of consumer pressure.

In 2023, the memory enhancement category generated the largest revenue share of around 30%.

The cause of this alarming rise is more susceptibility to mental health, such as dementia and Alzheimer's disease.

WHO reports that one in every four people has dementia, which is projected to reach 78 million by 2030.

The category Stress & anxiety that is the second fastest growing is the second

The statistical figure almost 3 out of 10 aged 13 to 18 will be diagnosed with an anxiety disorder.

The expected compound growth rate for depression and mood disorders is 8.9% in 2023.

A greater number of cases of depression, in particular vulnerable elders.

In 2023, the North American region had a 50% industry share because of growing cognitive health concerns and a robust sports sector.

Europe anticipates significant growth driven by mental well-being awareness and rising Alzheimer's cases.

APAC expects over 9.0% growth, led by concerns about brain health, stress, and education sector demand.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by region
  • 1.4.4. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Application (2017-2030)
• 6.4. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. AlternaScript LLC
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Natrol LLC
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Health Via Modern Nutrition Inc.
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. KeyView Labs Inc.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Natural Factors Nutritional Products Ltd.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Onnit Labs Inc.
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Peak Nootropics LLC
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Purelife Bioscience Co. Ltd.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Intelligent Labs
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. Accelerated Intelligence Inc.
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary
• 30.11. NOW Foods
  • 30.11.1. Business overview
  • 30.11.2. Product and service offerings
  • 30.11.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports